Sialidosis

Definition

Sialidosis is a severe inherited disorder that affects many organs and tissues, including the nervous system.

Alternate names

• cherry red spot myoclonus syndrome
• mucolipidosis I
• mucolipidosis type I
• myoclonus cherry red spot syndrome

Types

This disorder is divided into two types, which are distinguished by the age at which symptoms appear and the severity of features.

Epidemiology

The overall prevalence of sialidosis is unknown. Sialidosis type I appears to be more common in people with Italian ancestry.

Cause

Mutations in the NEU1 gene cause sialidosis. This gene provides instructions for making an enzyme called neuraminidase 1 (NEU1), which is found in lysosomes. Lysosomes are compartments within the cell that use enzymes to digest and recycle materials. The NEU1 enzyme helps break down large sugar molecules attached to certain proteins by removing a substance known as sialic acid.

Gene mutations

• Mutations in the NEU1 gene lead to a shortage (deficiency) of the NEU1 enzyme. When this enzyme is lacking, sialic acid-containing compounds accumulate inside lysosomes. Conditions such as sialidosis that cause molecules to build up inside lysosomes are called lysosomal storage disorders.
• People with sialidosis type II have mutations that severely reduce or eliminate NEU1 enzyme activity.
• Individuals with sialidosis type I have mutations that result in some functional NEU1 enzyme.
• It is unclear exactly how the accumulation of large molecules within lysosomes leads to the signs and symptoms of sialidosis.

Inheritance

Autosomal recessive inheritance, a 25% chance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Signs and symptoms

Sialidosis type I

• Sialidosis type I, also referred to as cherry-red spot myoclonus syndrome, is the less severe form of this condition.
• People with type I develop signs and symptoms of sialidosis in their teens or twenties.
• Initially, affected individuals experience problems walking (gait disturbance) and/or a loss of sharp vision (reduced visual acuity).
• Individuals with sialidosis type I also experience muscle twitches (myoclonus), difficulty coordinating movements (ataxia), leg tremors, and seizures. The myoclonus worsens over time, causing difficulty sitting, standing, or walking.
• People with sialidosis type I eventually require wheelchair assistance. Affected individuals have progressive vision problems, including impaired color vision or night blindness.
• An eye abnormality called a cherry-red spot, which can be identified with an eye examination, is characteristic of this disorder.
• Sialidosis type I does not affect intelligence or life expectancy.

Sialidosis type II Sialidosis type II, the more severe type of the disorder, is further divided into congenital, infantile, and juvenile forms.

The features of congenital sialidosis type II can develop before birth.

• This form of sialidosis is associated with an abnormal buildup of fluid in the abdominal cavity (ascites) or widespread swelling before birth caused by fluid accumulation (hydrops fetalis).
• Affected infants may also have an enlarged liver and spleen (hepatosplenomegaly), abnormal bone development (dysostosis multiplex), and distinctive facial features that are often described as "coarse."
• As a result of these serious health problems, individuals with congenital sialidosis type II usually are stillborn or die soon after birth.

• Infantile sialidosis type II shares some features with the congenital form, although the signs and symptoms are slightly less severe and begin within the first year of life.
• Features of the infantile form include hepatosplenomegaly, dysostosis multiplex, "coarse" facial features, short stature, and intellectual disability.
• As children with infantile sialidosis type II get older, they may develop myoclonus and cherry-red spots.
• Other signs and symptoms include hearing loss, overgrowth of the gums (gingival hyperplasia), and widely spaced teeth. Affected individuals may survive into childhood or adolescence.

The juvenile form has the least severe signs and symptoms of the different forms of sialidosis type II.

• Features of this condition usually appear in late childhood and may include mildly "coarse" facial features, mild bone abnormalities, cherry-red spots, myoclonus, intellectual disability, and dark red spots on the skin (angiokeratomas).
• The life expectancy of individuals with juvenile sialidosis type II varies depending on the severity of symptoms.

Diagnosis

Molecular Genetics Tests

• Deletion/duplication analysis
• Targeted variant analysis
• Sequence analysis of select exons
• Sequence analysis of the entire coding region

Treatment

There is no specific treatment for sialidosis. Management should be multidisciplinary and directed at supportive care and symptomatic relief. Overall health maintenance should be a priority, with seizure control as necessary. Myoclonic seizures often respond poorly to treatment with anticonvulsant medications.

NIH genetic and rare disease info

• NIH info on Sialidosis

Sialidosis is a rare disease.

Sialidosis Resources
Latest articles Most recent articles Ongoing trials	Wikipedia